DJ Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Quest Diagnostics Inc. $(DGX)$ shed 1.55% to $164.35 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.27% to 6,051.97 and Dow Jones Industrial Average falling 0.50% to 44,368.56.
The stock's fall snapped a two-day winning streak.
Quest Diagnostics Inc. closed 2.27% short of its 52-week high of $168.17, which the company achieved on February 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as UnitedHealth Group Inc. $(UNH)$ fell 1.22% to $527.40, IQVIA Holdings Inc. $(IQV)$ fell 1.53% to $197.82, and Centene Corp. $(CNC)$ fell 1.64% to $56.45.
Data source: Dow Jones Market Data, FactSet. Data compiled February 12, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 12, 2025 17:10 ET (22:10 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。